Sandostatin^® LAR^® Leaders Meeting – European Neuroendocrine Tumour Network ENET

Publisher： Karger

E-ISSN： 1421-9867|62|1|98-107

ISSN： 0012-2823

Source： Digestion, Vol.62, Iss.1, 2000-07, pp. : 98-107

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Effects of Sandostatin LAR on gastrointestinal motility in patients with neuroendocrine tumors

By Gregersen Tine Grøønbææk Henning Worsøøe Jonas Schlageter Vincent Laurberg Søøren Krogh Klaus

Scandinavian Journal of Gastroenterology, Vol. 46, Iss. 7-8, 2011-07 ,pp. : 895-902

Informa Healthcare

Access to resources Recommend Favorite

Clinical experience with Sandostatin LAR ( R) in patients with acromegaly

By Heijckmann C.A. Menheere P.P.C.A. Sels J.-P.J.E. Beuls E.A.M. Wolffenbuttel B.H.R.

The Netherlands Journal of Medicine, Vol. 59, Iss. 6, 2001-12 ,pp. : 286-291

Elsevier

Access to resources Recommend Favorite

Regression of a Large Malignant Gastrinoma on Treatment with Sandostatin LAR®: A Case Report

Digestion, Vol. 77, Iss. 2, 2008-03 ,pp. : 92-95

Karger

Access to resources Recommend Favorite

Analysis of neuroendocrine tumour metastases in the liver using contrast enhanced ultrasonography

By Mörk Hubert Ignee Andre Schuessler Gudrun Ott Michaela Dietrich Christoph F.

Scandinavian Journal of Gastroenterology, Vol. 42, Iss. 5, 2007-01 ,pp. : 652-662

Informa Healthcare

Access to resources Recommend Favorite

An Unusual Metastatic Motilin-Secreting Neuroendocrine Tumour with a 20-Year Survival

Digestion, Vol. 64, Iss. 4, 2009-01 ,pp. : 255-260

Karger

Access to resources Recommend Favorite